Protara Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Protara Therapeutics has a total shareholder equity of $92.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $101.6M and $9.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$89.58m |
| Equity | US$92.05m |
| Total liabilities | US$9.60m |
| Total assets | US$101.65m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1KPA's short term assets ($92.2M) exceed its short term liabilities ($5.6M).
Long Term Liabilities: 1KPA's short term assets ($92.2M) exceed its long term liabilities ($3.9M).
Debt to Equity History and Analysis
Debt Level: 1KPA is debt free.
Reducing Debt: 1KPA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1KPA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1KPA has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 22.7% each year.